Publication Details
| Pubmed | 26228206 |
| Title: | The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy in Pancreatic Cancer Models by Altering Ribonucleotide Reductase Subunit-1 (RRM1). |
| Year: | 2015 |
| DOI: | https://doi.org/10.1158/1078-0432.CCR-15-0485 |
| First Author: | Vena |
| Experimental setup: | affinity chromatography technology (Biogrid) |
| Throughput: | Low Throughput (Biogrid) |
Interactions